The Diabetes Canada pharmacotherapy in type 2 diabetes guideline chapter was recently updated. After completing this module, primary care clinicians should be able to interpret the latest guideline evidence, apply them to clinical cases and be more comfortable integrating the new recommendations into their practices.
This program is developed in collaboration with Partners in Progressive Medical Education (PPME), and endorsed by Diabetes Canada.
This program has received an educational grant or in-kind support from Abbott Diabetes Care, Astra Zeneca, Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc., Janssen, Novo Nordisk and Sanofi.